XML 34 R37.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2012
Fair Value Disclosures [Abstract]  
Summary of Assets and Liabilities Recorded at Fair Value
(In millions)
As of
September 30,
2012
 
Quoted Prices
in Active
Markets
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
Cash equivalents
$
309.0

 
$

 
$
309.0

 
$

Marketable debt securities:
 
 
 
 
 
 
 
Corporate debt securities
914.7

 

 
914.7

 

Government securities
1,539.9

 

 
1,539.9

 

Mortgage and other asset backed securities
441.0

 

 
441.0

 

Marketable equity securities
1.2

 
1.2

 

 

Venture capital investments
25.2

 

 

 
25.2

Derivative contracts
6.9

 

 
6.9

 

Plan assets for deferred compensation
13.9

 

 
13.9

 

Total
$
3,251.8

 
$
1.2

 
$
3,225.4

 
$
25.2

Liabilities:
 
 
 
 
 
 
 
Derivative contracts
$
5.2

 
$

 
$
5.2

 
$

Contingent consideration obligations
290.3

 

 

 
290.3

Total
$
295.5

 
$

 
$
5.2

 
$
290.3


(In millions)
As of
December 31,
2011
 
Quoted Prices
in Active
Markets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
Cash equivalents
$
399.8

 
$

 
$
399.8

 
$

Marketable debt securities:
 
 
 
 
 
 
 
Corporate debt securities
602.6

 

 
602.6

 

Government securities
1,716.5

 

 
1,716.5

 

Mortgage and other asset backed securities
273.8

 

 
273.8

 

Marketable equity securities
0.1

 
0.1

 

 

Venture capital investments
23.5

 

 

 
23.5

Derivative contracts
39.5

 

 
39.5

 

Plan assets for deferred compensation
11.6

 

 
11.6

 

Total
$
3,067.4

 
$
0.1

 
$
3,043.8

 
$
23.5

Liabilities:
 
 
 
 
 
 
 
Derivative contracts
$
0.5

 
$

 
$
0.5

 
$

Contingent consideration obligations
151.0

 

 

 
151.0

Total
$
151.5

 
$

 
$
0.5

 
$
151.0

Fair value of venture capital investments
 
For the Three Months
Ended September 30,
 
For the Nine Months
Ended September 30,
(In millions)
2012
 
2011
 
2012
 
2011
Fair value, beginning of period
$
25.4

 
$
20.6

 
$
23.5

 
$
20.8

Unrealized gains included in earnings
1.4

 
1.8

 
4.9

 
2.5

Unrealized losses included in earnings
(1.6
)
 
(0.2
)
 
(3.6
)
 
(1.5
)
Purchases

 
0.9

 
0.4

 
1.3

Fair value, end of period
$
25.2

 
$
23.1

 
$
25.2

 
$
23.1

Summary of fair and carrying value of debt instruments
 
As of September 30, 2012
 
As of December 31, 2011
(In millions)
Fair
Value
 
Carrying
Value
 
Fair
Value
 
Carrying
Value
Notes payable to Fumedica
$
18.9

 
$
17.2

 
$
22.4

 
$
19.7

6.0% Senior Notes due March 1, 2013
459.6

 
450.0

 
474.1

 
449.9

6.875% Senior Notes due March 1, 2018
666.4

 
587.9

 
663.9

 
592.3

Total
$
1,144.9

 
$
1,055.1

 
$
1,160.4

 
$
1,061.9

Fair value of contingent consideration obligations
 
For the Three Months
Ended September 30,
 
For the Nine Months
Ended September 30,
(In millions)
2012
 
2011
 
2012
 
2011
Fair value, beginning of period
$
280.9

 
$
84.6

 
$
151.0

 
$
81.2

Additions

 
38.8

 
122.2

 
38.8

Changes in fair value
9.4

 
2.5

 
23.6

 
5.9

Payments

 

 
(6.5
)
 

Fair value, end of period
$
290.3

 
$
125.9

 
$
290.3

 
$
125.9